[ad_1]
LONDON: The European Union’s drug regulator said on Monday it could issue “within weeks” a decision on whether to approve the use of Pfizer’s Covid-19 pill, Paxlovid, after the US drugmaker submitted an application seeking authorisation.
The approval sought is for the treatment of mild-to-moderate Covid-19 in patients 12 years of age and older, weighing at least 40 kilograms and are at high risk of their illness worsening, the European Medicines Agency said.
The approval sought is for the treatment of mild-to-moderate Covid-19 in patients 12 years of age and older, weighing at least 40 kilograms and are at high risk of their illness worsening, the European Medicines Agency said.
[ad_2]
Source link
